Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record history now lists the latest revision as v3.6.6, replacing the previous version v3.6.5.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record history now includes a new revision entry v3.6.5. The previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check49 days agoChange DetectedA new Revision: v3.6.4 entry was added and the previous Revision: v3.6.3 entry was removed in the study record history, indicating a small backend/UI update reflected in the log.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history section now includes new entries for eligibility and study status, with a latest version noted as 27 around 2026-07-09 and an entry for 2026-07-10; an older entry from 2026-04-08 has been removed.SummaryDifference0.4%

- Check71 days agoChange DetectedRevision label updated to v3.6.3 in the page history, replacing the previous v3.6.2. This reflects a minor update to the page rendering or metadata for the study record, without changes to the study data.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page history now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects an update to the record history’s versioning metadata.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.